Literature DB >> 21179187

Management of metabolic complications and cardiovascular risk in HIV-infected patients.

Francisco Blanco1, Jesús San Román, Eugenia Vispo, Mariola López, Antonio Salto, Vanesa Abad, Vincent Soriano.   

Abstract

As result of the great benefit of HAART, AIDS-related deaths have dramatically declined during the last decade in HIV-infected individuals. However, mortality due to non-AIDS conditions and particularly cardiovascular events seems to be on the rise in this population. Metabolic complications and other conditions responsible for increased cardiovascular risk are common in HIV persons. Moreover, antiretroviral medications and HIV itself might play a role in further increasing cardiovascular risk. As the HIV population is aging, a growing impact of cardiovascular events on survival can be expected. Therefore, early diagnosis and treatment of predisposing cardiovascular risk factors is warranted in this population. In this way, all HIV-infected individuals should be evaluated regularly for lipid abnormalities, hyperglycemia, arterial hypertension, overweight, renal disease, and smoking. The individual´s absolute risk for coronary heart disease must be defined, and comprehensive therapeutic measures should be undertaken in order to minimize future complications in subjects with significant cardiovascular risk. Lifestyle habits must be encouraged, including healthy diet and exercise. Switches in antiretroviral regimens using metabolic-friendly agents should also be considered for managing mild metabolic abnormalities in lipids and glucose, as long as suppression of viral replication is not compromised. The management of overt lipid disorders, diabetes, and hypertension basically must follow the guidelines applied to the general population and specific drugs administered, taking into account the potential for drug interactions with antiretroviral agents. In summary, efforts for reducing the increased cardiovascular risk characteristically seen in HIV-infected individuals are warranted, and preventable factors, including adequate management of metabolic abnormalities and hypertension, along with promotion of lifestyle habits and smoke cessation, should no longer be neglected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21179187

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  12 in total

1.  Does HIV infection increase the risk of perioperative complications after THA? A nationwide database study.

Authors:  Qais Naziri; Matthew R Boylan; Kimona Issa; Lynne C Jones; Harpal S Khanuja; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

2.  HIV-associated mucosal gene expression: region-specific alterations.

Authors:  Robin M Voigt; Ali Keshavarzian; John Losurdo; Garth Swanson; Basile Siewe; Christopher B Forsyth; Audrey L French; Patricia Demarais; Phillip Engen; Shohreh Raeisi; Ece Mutlu; Alan L Landay
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

3.  Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones.

Authors:  Debasis Mondal; Kai Liu; Milton Hamblin; Joseph A Lasky; Krishna C Agrawal
Journal:  Ochsner J       Date:  2013

4.  Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.

Authors:  Steven E Lipshultz; James D Wilkinson; Bruce Thompson; Irene Cheng; David A Briston; William T Shearer; E John Orav; Joslyn A Westphal; Tracie L Miller; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094

5.  Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study.

Authors:  Stefan Esser; Götz Gelbrich; Norbert Brockmeyer; Alexander Goehler; Dirk Schadendorf; Raimund Erbel; Till Neumann; Nico Reinsch
Journal:  Clin Res Cardiol       Date:  2012-11-02       Impact factor: 5.460

6.  Prevalence of traditional cardiovascular risk factors and evaluation of cardiovascular risk using three risk equations in nigerians living with human immunodeficiency virus.

Authors:  Ayodele Olugbenga Edward; Akinboro Adeolu Oladayo; Akinyemi Suliat Omolola; Adepeju Akinlawon Adetiloye; Popoola Adetoun Adedayo
Journal:  N Am J Med Sci       Date:  2013-12

7.  Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China.

Authors:  Yinzhong Shen; Zhenyan Wang; Li Liu; Renfang Zhang; Yufang Zheng; Hongzhou Lu
Journal:  BMC Infect Dis       Date:  2013-02-11       Impact factor: 3.090

8.  Metabolic Status and Hypogonadism in Human Immunodeficiency Virus-infected Males.

Authors:  Sarita Bajaj; Yashaswi Pathak; Sharad Varma; Sujit Verma
Journal:  Indian J Endocrinol Metab       Date:  2017 Sep-Oct

9.  Effects of a 6-week aerobic exercise programme on the cardiovascular parameters, body composition, and quality of life of people living with human immune virus.

Authors:  Davidson Okwudili John; Bosede A Tella; Olajide A Olawale; Jeneviv N John; Titilope A Adeyemo; Obinna C Okezue
Journal:  J Exerc Rehabil       Date:  2018-10-31

10.  Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China.

Authors:  Yinzhong Shen; Jiangrong Wang; Zhenyan Wang; Tangkai Qi; Wei Song; Yang Tang; Li Liu; Renfang Zhang; Hongzhou Lu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.